Search





Search





Markets
/
Stocks
/
autl
/

Autolus Therapeutics PLC

AUTL

Add to Watchlist

1.490USD

-0.040-2.61%

Close 07-31 16:00（ET）Quotes delayed by 15 min

396.57MMarket Cap

LossP/E TTM

Autolus Therapeutics PLC

1.490

-0.040-2.61%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

AUTL Income Statement

You can find the annual or quarterly income statement of Autolus Therapeutics PLC here for insights into the performance and operational efficiency of Autolus Therapeutics PLC.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

Total revenue

191.89%26.22M

83655.17%24.29M

--21.19M

--20.92M

-10.99%8.98M

--29.00K

-100.00%0.00

----

681.04%10.09M

-100.00%0.00

-82.86%406.00K

----

678.31%1.29M

2025.00%3.83M

903.81%2.37M

-100.00%0.00

-38.29%166.00K

-55.45%180.00K

-65.29%236.00K

461.43%1.65M

-20.41%269.00K

30.74%404.00K

128.96%680.00K

-13.31%293.00K

-82.79%338.00K

--309.00K

--297.00K

--338.00K

--1.96M

Revenue

191.89%26.22M

--23.27M

--21.14M

--20.92M

--8.98M

----

Cost of revenue

36.86%24.57M

122.45%25.33M

--28.64M

--24.45M

--17.95M

--11.39M

----

Operating expenses

15.51%85.73M

27.49%96.75M

37.19%92.81M

40.37%82.14M

51.94%74.22M

85.62%75.89M

57.59%67.65M

31.93%58.52M

33.20%48.85M

173.30%40.89M

-6.40%42.93M

-4.58%44.35M

-12.58%36.67M

-35.73%14.96M

12.99%45.86M

18.07%46.48M

6.29%41.95M

-51.24%23.28M

-6.45%40.59M

-1.18%39.37M

1.46%39.47M

21.49%47.73M

20.81%43.39M

6.11%39.84M

21.11%38.90M

--39.29M

--35.91M

--37.54M

--32.12M

R&D expenses

-20.66%21.21M

15.58%35.63M

-30.83%27.89M

-25.08%27.43M

-12.84%26.73M

22.55%30.83M

24.77%40.32M

10.17%36.61M

11.99%30.67M

233.31%25.16M

-14.12%32.32M

-13.03%33.23M

-16.58%27.39M

-51.88%7.55M

16.54%37.63M

18.93%38.21M

6.83%32.83M

-59.50%15.69M

-3.74%32.29M

2.56%32.13M

-1.78%30.73M

37.02%38.73M

28.40%33.55M

24.92%31.33M

45.04%31.29M

--28.26M

--26.13M

--25.08M

--21.57M

Depreciation, depletion, and amortization

17.78%2.71M

32.10%2.64M

34.16%2.60M

26.32%2.40M

27.35%2.30M

11.11%2.00M

38.43%1.94M

25.66%1.90M

-4.95%1.81M

9.16%1.80M

-21.66%1.40M

-21.21%1.51M

-8.08%1.90M

-21.63%1.65M

-27.00%1.79M

-12.77%1.92M

14.83%2.07M

23.76%2.10M

63.20%2.45M

73.64%2.20M

38.46%1.80M

31.89%1.70M

31.35%1.50M

134.20%1.27M

-20.68%1.30M

--1.29M

--1.14M

--541.00K

--1.64M

Other operating expenses

----

---3.00K

----

--0.00

----

Operating profit

8.77%-59.51M

4.48%-72.47M

-5.87%-71.62M

-4.62%-61.22M

-68.32%-65.24M

-85.55%-75.86M

-59.10%-67.65M

-31.93%-58.52M

-9.54%-38.76M

-267.18%-40.89M

2.23%-42.52M

4.58%-44.35M

15.33%-35.38M

51.79%-11.13M

-7.78%-43.49M

-23.22%-46.48M

-6.59%-41.78M

51.20%-23.10M

5.51%-40.35M

4.60%-37.72M

-1.65%-39.20M

-21.42%-47.33M

-19.91%-42.71M

-6.29%-39.54M

-27.87%-38.56M

---38.98M

---35.62M

---37.20M

---30.16M

Net non-operating interest income (expenses)

Non-operating interest income

-59.77%2.47M

-91.57%3.23M

-47.33%4.38M

24.93%12.06M

-11.48%6.14M

1171.83%38.28M

128.20%8.32M

183.75%9.66M

101.19%6.93M

111.08%3.01M

2109.70%3.65M

3723.60%3.40M

12207.14%3.45M

857.05%1.43M

489.29%165.00K

111.90%89.00K

-36.36%28.00K

313.89%149.00K

-24.32%28.00K

--42.00K

-91.37%44.00K

-91.39%36.00K

-92.73%37.00K

----

-5.73%510.00K

--418.00K

--509.00K

--1.07M

--541.00K

Non-operating interest expense

9.67%11.12M

--22.84M

-1.55%10.52M

----

-47.36%10.14M

----

113.12%10.69M

102.67%10.17M

292.84%19.27M

771.51%30.13M

171.03%5.01M

177.35%5.02M

174.02%4.91M

212.85%3.46M

--1.85M

--1.81M

--1.79M

--1.10M

----

Gains from sale of securities

-325.83%-2.67M

-96.54%394.00K

92.33%-911.00K

--1.50M

--1.18M

337.65%11.38M

-585.75%-11.88M

----

44.44%2.60M

---1.73M

----

1900.00%1.80M

----

166.67%800.00K

---100.00K

--1.00M

---1.90M

---1.20M

----

Special income (expenses)

----

--0.00

100.00%0.00

----

--0.00

100.00%0.00

---414.00K

----

--0.00

---382.00K

--0.00

----

100.00%0.00

---1.30M

----

---4.10M

----

- Gains from disposal of fixed assets

----

100.00%0.00

--0.00

---3.00K

--0.00

---223.00K

100.00%0.00

--0.00

---23.00K

---3.77M

-12775.00%-515.00K

--0.00

100.00%0.00

---4.00K

--0.00

---672.00K

----

Other non-operating income (expenses)

-22.48%100.00K

181.36%166.00K

55.56%84.00K

-88.99%135.00K

108.04%129.00K

-90.07%59.00K

-60.29%54.00K

154.36%1.23M

-305.24%-1.60M

-86.66%594.00K

103.64%136.00K

136.21%482.00K

1203.33%782.00K

31700.00%4.45M

-7532.65%-3.74M

-2709.80%-1.33M

-97.06%60.00K

101.22%14.00K

95.95%-49.00K

-90.29%51.00K

-54.55%2.04M

46.48%-1.15M

-137.05%-1.21M

-88.01%525.00K

555.69%4.48M

---2.15M

--3.26M

--4.38M

---984.00K

Income before tax

-4.12%-70.73M

-250.04%-91.52M

4.25%-78.59M

18.38%-47.52M

-28.92%-67.94M

59.66%-26.14M

-78.92%-82.07M

-27.92%-58.22M

-32.32%-52.70M

-772.39%-64.81M

6.23%-45.87M

8.12%-45.51M

6.70%-39.83M

69.23%-7.43M

-24.24%-48.92M

-25.30%-49.53M

-9.48%-42.69M

50.16%-24.14M

12.85%-39.38M

-1.19%-39.53M

-16.15%-38.99M

-8.11%-48.44M

-41.87%-45.18M

-23.03%-39.07M

-9.70%-33.57M

---44.81M

---31.85M

---31.75M

---30.60M

Income tax

-61.21%863.00K

-180.92%-1.18M

2318.18%532.00K

678.43%397.00K

27912.50%2.23M

-88.17%1.46M

204.76%22.00K

27.50%51.00K

42.86%-8.00K

-36.68%12.36M

99.66%-21.00K

100.54%40.00K

99.75%-14.00K

11.40%19.52M

-14.24%-6.15M

-17.57%-7.47M

1.75%-5.62M

413.99%17.52M

31.53%-5.38M

9.46%-6.36M

-54.87%-5.72M

-44.40%-5.58M

-71.05%-7.87M

-114.45%-7.02M

-8.04%-3.70M

---3.87M

---4.60M

---3.27M

---3.42M

Income after tax

-2.05%-71.60M

-227.22%-90.33M

3.63%-79.12M

17.77%-47.92M

-33.16%-70.16M

64.23%-27.61M

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-186.34%-77.17M

-7.21%-45.85M

-8.31%-45.55M

-7.42%-39.81M

35.32%-26.95M

-25.82%-42.77M

-26.79%-42.06M

-11.41%-37.06M

2.79%-41.67M

8.91%-33.99M

-3.52%-33.17M

-11.36%-33.27M

-4.68%-42.86M

-36.95%-37.31M

-12.53%-32.05M

-9.91%-29.87M

---40.94M

---27.25M

---28.48M

---27.18M

Net income from continuous operations

-2.05%-71.60M

-227.22%-90.33M

3.63%-79.12M

17.77%-47.92M

-33.16%-70.16M

64.23%-27.61M

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-186.34%-77.17M

-7.21%-45.85M

-8.31%-45.55M

-7.42%-39.81M

35.32%-26.95M

-25.82%-42.77M

-26.79%-42.06M

-11.41%-37.06M

2.79%-41.67M

8.91%-33.99M

-3.52%-33.17M

-11.36%-33.27M

-4.68%-42.86M

-36.94%-37.31M

-12.53%-32.05M

-9.91%-29.87M

---40.94M

---27.25M

---28.48M

---27.18M

Other net gains and losses

----

---2.00K

----

Net income attributable to controlling interests

-2.05%-71.60M

-227.22%-90.33M

3.63%-79.12M

17.77%-47.92M

-33.16%-70.16M

64.23%-27.61M

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-186.34%-77.17M

-7.21%-45.85M

-8.31%-45.55M

-7.42%-39.81M

35.32%-26.95M

-25.82%-42.77M

-26.79%-42.06M

-11.41%-37.06M

2.79%-41.67M

8.91%-33.99M

-3.52%-33.17M

-11.36%-33.27M

-4.68%-42.86M

-36.95%-37.31M

-12.53%-32.05M

-9.91%-29.87M

---40.94M

---27.25M

---28.48M

---27.18M

Net income attributable to common shareholders

-2.05%-71.60M

-227.22%-90.33M

3.63%-79.12M

17.77%-47.92M

-33.16%-70.16M

64.23%-27.61M

-79.05%-82.09M

-27.92%-58.27M

-32.35%-52.69M

-186.34%-77.17M

-7.21%-45.85M

-8.31%-45.55M

-7.42%-39.81M

35.32%-26.95M

-25.82%-42.77M

-26.79%-42.06M

-11.41%-37.06M

2.79%-41.67M

8.91%-33.99M

-3.52%-33.17M

-11.36%-33.27M

-4.68%-42.86M

-36.95%-37.31M

-12.53%-32.05M

-9.91%-29.87M

---40.94M

---27.25M

---28.48M

---27.18M

Basic earnings per share

-2.04%-0.27

-227.30%-0.34

3.65%-0.30

17.81%-0.18

-11.17%-0.26

76.61%-0.10

-17.08%-0.31

16.39%-0.22

-3.55%-0.24

-75.80%-0.44

43.78%-0.26

43.36%-0.26

43.82%-0.23

50.36%-0.25

-0.52%-0.47

1.24%-0.46

23.47%-0.41

38.12%-0.51

34.90%-0.47

23.94%-0.47

11.09%-0.53

10.54%-0.82

-17.08%-0.72

5.70%-0.62

12.99%-0.60

---0.92

---0.61

---0.65

---0.69

Diluted earnings per share

-2.04%-0.27

-227.30%-0.34

3.65%-0.30

17.81%-0.18

-11.17%-0.26

76.61%-0.10

-17.08%-0.31

16.39%-0.22

-3.55%-0.24

-75.80%-0.44

43.78%-0.26

43.36%-0.26

43.82%-0.23

50.36%-0.25

-0.52%-0.47

1.24%-0.46

23.47%-0.41

38.12%-0.51

34.90%-0.47

23.94%-0.47

11.09%-0.53

10.54%-0.82

-17.08%-0.72

5.70%-0.62

12.99%-0.60

---0.92

---0.61

---0.65

---0.69

Dividend per share

----

--0.00

----

--0.00

----

--0.00

----

--0.00

Currency unit

--USD

Audit opinions

----

FAQs

How do I read Autolus Therapeutics PLC's income statement on TradingKey?



Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?



A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?



YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing AUTL stock?



Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Autolus Therapeutics PLC's revenue at year end?



Autolus Therapeutics PLC reported 75.39M in revenue for fiscal year 2025, up from 10.12M in the previous year.

How much revenue did Autolus Therapeutics PLC report in the most recent quarter?



Autolus Therapeutics PLC reported 26.22M in revenue for the most recent quarter, an increase of 191.89% year over year.

What was Autolus Therapeutics PLC's net income for the year?



Autolus Therapeutics PLC posted -287.53M in net income for fiscal year 2025.

How much net income did Autolus Therapeutics PLC post in the last quarter?



Autolus Therapeutics PLC reported -71.60M in net income for the latest quarter。

What was Autolus Therapeutics PLC's annual operating profit?



Autolus Therapeutics PLC's operating income was -270.24M for fiscal year 2025.

How is EPS related to the income statement?



EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.